and biofilm treatment
The BioFlux system is a microfluidic platform designed to run automated shear flow protocols microbiology experiments. A 48-well BioFlux plate can run up to 24 experiments simultaneously. To increase performance even further, the BioFlux Quattro system operates up to 4 plates in parallel, or 96 total experiments. Typically these experiments are run as end point assays with the Quattro system set up on the lab bench or in a hood.
In the paper below, various compounds were tested to determine their ability to prevent or eradicate biofilms.
(A) S. mutans biofilms were cultured in a BioFlux system for 18 to 24 hours, inoculated with different antibacterial agents, and stained (live cells stained green and dead cells stained red). (B) These results were graphed, showing statistically significant differences between the control and the antimicrobial-treated groups (Ding et al., 2014).
S. mutans was grown on a BioFlux plate, then treated with pleurocidin, and stained (green being the live cells and red being dead). Bacteria on the outside of the biofilm was killed by the antimicrobial agent, whereas the bacteria closer to the inside of the biofilm was protected by the surroundings (Tao et al., 2011).
Key BioFlux Advantages For Antimicrobial Screening Studies
Analyze the effectiveness of different antimicrobial compounds by growing biofilms under controlled shear flow, mimicking the conditions of natural growth
Use the all silicone plate format for antimicrobial compounds relating to catheter-associated infections
Custom substrate plates feature the ability to add any material to the bottom of microfluidic flow chambers, and enable a full range of experimental protocols for a variety of microbes and antimicrobial compounds
Discover new antimicrobial compounds and help eradicate antibiotic tolerance and susceptibility with a flow-based system